Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.02%
1,089.29
-11.28
-1.02%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.25%
603.63
-1.52
-0.25%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+2.04%
1,219.54
+24.35
+2.04%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.22%
1,718.73
-21.18
-1.22%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.52%
641.89
+3.33
+0.52%
—638.56640.21645.32639.66——
SIXR
Staples
SIXR
Staples
SIXR
+1.41%
843.29
+11.72
+1.41%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.88%
215.24
+1.88
+0.88%
—213.36213.36215.54212.77——
SIXT
Technology
SIXT
Technology
SIXT
-2.25%
3,161.45
-72.73
-2.25%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.38%
939.24
+3.59
+0.38%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.40%
1,455.02
+5.76
+0.40%
—1,449.261,454.771,462.651,452.87——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.49%
2,370.77
-11.41
-0.49%
—2,382.452,371.192,380.452,364.46——
LONA:NASDAQ
LeonaBio Inc
$8.51
+1.92%
(+0.16) 1D
Apr 28, 10:53:35 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LONA...
Open
$8.64
High
$8.64
Low
$8.51
Mkt. cap
79.94M
Avg. vol.
79.22K
Volume
4.00K
52-wk high
$14.21
52-wk low
$4.21
EPS
-$24.70
Beta
2.22
Shares outstanding
9.39M
No. of employees
19
News stories
From sources across the web
Profile
Athira Pharma is a late clinical stage American biopharmaceutical company developing small-molecule therapeutics targeting neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021. The company was founded in 2011 and is headquartered in Seattle. Funding that supports the company is from both public and private investment groups including the Alzheimer's Drug Discovery Foundation, Dolby Family Ventures, the State of Washington's Life Sciences Discovery Fund, The W Fund, WRF Capital, and other private investors. Leen Kawas served as the company's first President and CEO, but resigned in October 2021, after an independent special committee found she "altered images in scientific papers she authored." In 2025, the company paid a $4 million settlement in relation to allegations that the CEO falsified research to secure a federal grant. On October 21, 2021, Mark Litton, Ph.D., M.B.A. became chief executive officer. Wikipedia
About LeonaBio Inc
CEO-
Employees19
Founded2011
HeadquartersBothell, Washington, United States
SectorPharmaceutical industry
Websiteleonabio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.30M
3.66M
2.82M
6.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.23M
3.63M
4.05M
3.76M
Operating expense
9.54M
7.29M
6.87M
10.48M
Total operating expenses
9.54M
7.29M
6.87M
10.48M
Operating income
-9.54M
-7.29M
-6.87M
-10.48M
Other non operating income
328.00K
325.00K
263.00K
-4.39M
EBT including unusual items
-9.14M
-6.97M
-6.61M
-82.89M
EBT excluding unusual items
-9.21M
-6.97M
-6.61M
-14.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.14M
-6.97M
-6.61M
-82.89M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.29M
-7.05M
-6.63M
-10.23M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer